Report Thumbnail
Product Code LP091200348BX7
Published Date 2024/1/11
English137 PagesGlobal

Global Marine Pharmaceuticals Market Growth 2024-2030Pharmaceutical_LifeSciense Market


Report Thumbnail
Product Code LP091200348BX7◆The Jan 2026 edition is also likely available. We will check with the publisher immediately.
Published Date 2024/1/11
English 137 PagesGlobal

Global Marine Pharmaceuticals Market Growth 2024-2030Pharmaceutical_LifeSciense Market



Abstract


Summary

According to our LPI (LP Information) latest study, the global Marine Pharmaceuticals market size was valued at US$ 28860 million in 2023. With growing demand in downstream market, the Marine Pharmaceuticals is forecast to a readjusted size of US$ 52140 million by 2030 with a CAGR of 8.8% during review period. _x000D_ The research report highlights the growth potential of the global Marine Pharmaceuticals market. Marine Pharmaceuticals are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Marine Pharmaceuticals. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Marine Pharmaceuticals market._x000D_ The drug obtained from marine organisms which are being conventionally used like shark and cod-liver oils, sodium alginate, agar-agar, chitin etc. Marine organisms are potential source for drug discovery. Life has originated from the oceans that cover over 70% of the surface of earth and contain highly ecological, chemical and biological diversity starting from micro-organisms to vertebrates. This diversity has been the source of unique chemical compounds, which hold tremendous pharmaceutical potential._x000D_ Global Marine Pharmaceuticals key players include Seattle Genetics, Inc., DSM, Eisai Co, Takeda, BASF, Amway, etc. Global top six manufacturers hold a share about 10%. North America is the largest market, with a share about 35%, followed by Europe and China, both have a share over 35 percent. In terms of product, Health Supplement is the largest segment, with a share about 90%. And in terms of application, the largest application is Pharmacy, followed by Hospital & Clinic._x000D_ Key Features:_x000D_ The report on Marine Pharmaceuticals market reflects various aspects and provide valuable insights into the industry._x000D_ Market Size and Growth: The research report provide an overview of the current size and growth of the Marine Pharmaceuticals market. It may include historical data, market segmentation by Type (e.g., Drugs, Health Supplement), and regional breakdowns._x000D_ Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Marine Pharmaceuticals market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs._x000D_ Competitive Landscape: The research report provides analysis of the competitive landscape within the Marine Pharmaceuticals market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market._x000D_ Technological Developments: The research report can delve into the latest technological developments in the Marine Pharmaceuticals industry. This include advancements in Marine Pharmaceuticals technology, Marine Pharmaceuticals new entrants, Marine Pharmaceuticals new investment, and other innovations that are shaping the future of Marine Pharmaceuticals._x000D_ Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Marine Pharmaceuticals market. It includes factors influencing customer ' purchasing decisions, preferences for Marine Pharmaceuticals product._x000D_ Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Marine Pharmaceuticals market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Marine Pharmaceuticals market. The report also evaluates the effectiveness of these policies in driving market growth._x000D_ Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Marine Pharmaceuticals market. _x000D_ Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Marine Pharmaceuticals industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments._x000D_ Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Marine Pharmaceuticals market._x000D_ Market Segmentation:_x000D_ Marine Pharmaceuticals market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value._x000D_ Segmentation by type_x000D_ Drugs_x000D_ Health Supplement_x000D_ Segmentation by application_x000D_ Hospital & Clinic_x000D_ Pharmacy_x000D_ Other_x000D_ This report also splits the market by region:_x000D_ Americas_x000D_ United States_x000D_ Canada_x000D_ Mexico_x000D_ Brazil_x000D_ APAC_x000D_ China_x000D_ Japan_x000D_ Korea_x000D_ Southeast Asia_x000D_ India_x000D_ Australia_x000D_ Europe_x000D_ Germany_x000D_ France_x000D_ UK_x000D_ Italy_x000D_ Russia_x000D_ Middle East & Africa_x000D_ Egypt_x000D_ South Africa_x000D_ Israel_x000D_ Turkey_x000D_ GCC Countries_x000D_ The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration._x000D_ Seattle Genetics_x000D_ DSM_x000D_ Eisai Co_x000D_ Takeda_x000D_ BASF_x000D_ Amway_x000D_ Pfizer_x000D_ Pelagia (EPAX)_x000D_ Pharma Mar SA_x000D_ Croda_x000D_ GNC_x000D_ GSK_x000D_ TerSera Therapeutics_x000D_ Nordic Naturals_x000D_ Carlson Labs_x000D_ Key Questions Addressed in this Report_x000D_ What is the 10-year outlook for the global Marine Pharmaceuticals market?_x000D_ What factors are driving Marine Pharmaceuticals market growth, globally and by region?_x000D_ Which technologies are poised for the fastest growth by market and region?_x000D_ How do Marine Pharmaceuticals market opportunities vary by end market size?_x000D_ How does Marine Pharmaceuticals break out type, application?_x000D_

Table of Contents

  • 1 Scope of the Report

    • 1.1 Market Introduction
    • 1.2 Years Considered
    • 1.3 Research Objectives
    • 1.4 Market Research Methodology
    • 1.5 Research Process and Data Source
    • 1.6 Economic Indicators
    • 1.7 Currency Considered
    • 1.8 Market Estimation Caveats
  • 2 Executive Summary

    • 2.1 World Market Overview
      • 2.1.1 Global Marine Pharmaceuticals Annual Sales 2019-2030
      • 2.1.2 World Current & Future Analysis for Marine Pharmaceuticals by Geographic Region, 2019, 2023 & 2030
      • 2.1.3 World Current & Future Analysis for Marine Pharmaceuticals by Country/Region, 2019, 2023 & 2030
    • 2.2 Marine Pharmaceuticals Segment by Type
      • 2.2.1 Drugs
      • 2.2.2 Health Supplement
    • 2.3 Marine Pharmaceuticals Sales by Type
      • 2.3.1 Global Marine Pharmaceuticals Sales Market Share by Type (2019-2024)
      • 2.3.2 Global Marine Pharmaceuticals Revenue and Market Share by Type (2019-2024)
      • 2.3.3 Global Marine Pharmaceuticals Sale Price by Type (2019-2024)
    • 2.4 Marine Pharmaceuticals Segment by Application
      • 2.4.1 Hospital & Clinic
      • 2.4.2 Pharmacy
      • 2.4.3 Other
    • 2.5 Marine Pharmaceuticals Sales by Application
      • 2.5.1 Global Marine Pharmaceuticals Sale Market Share by Application (2019-2024)
      • 2.5.2 Global Marine Pharmaceuticals Revenue and Market Share by Application (2019-2024)
      • 2.5.3 Global Marine Pharmaceuticals Sale Price by Application (2019-2024)
  • 3 Global Marine Pharmaceuticals by Company

    • 3.1 Global Marine Pharmaceuticals Breakdown Data by Company
      • 3.1.1 Global Marine Pharmaceuticals Annual Sales by Company (2019-2024)
      • 3.1.2 Global Marine Pharmaceuticals Sales Market Share by Company (2019-2024)
    • 3.2 Global Marine Pharmaceuticals Annual Revenue by Company (2019-2024)
      • 3.2.1 Global Marine Pharmaceuticals Revenue by Company (2019-2024)
      • 3.2.2 Global Marine Pharmaceuticals Revenue Market Share by Company (2019-2024)
    • 3.3 Global Marine Pharmaceuticals Sale Price by Company
    • 3.4 Key Manufacturers Marine Pharmaceuticals Producing Area Distribution, Sales Area, Product Type
      • 3.4.1 Key Manufacturers Marine Pharmaceuticals Product Location Distribution
      • 3.4.2 Players Marine Pharmaceuticals Products Offered
    • 3.5 Market Concentration Rate Analysis
      • 3.5.1 Competition Landscape Analysis
      • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
    • 3.6 New Products and Potential Entrants
    • 3.7 Mergers & Acquisitions, Expansion
  • 4 World Historic Review for Marine Pharmaceuticals by Geographic Region

    • 4.1 World Historic Marine Pharmaceuticals Market Size by Geographic Region (2019-2024)
      • 4.1.1 Global Marine Pharmaceuticals Annual Sales by Geographic Region (2019-2024)
      • 4.1.2 Global Marine Pharmaceuticals Annual Revenue by Geographic Region (2019-2024)
    • 4.2 World Historic Marine Pharmaceuticals Market Size by Country/Region (2019-2024)
      • 4.2.1 Global Marine Pharmaceuticals Annual Sales by Country/Region (2019-2024)
      • 4.2.2 Global Marine Pharmaceuticals Annual Revenue by Country/Region (2019-2024)
    • 4.3 Americas Marine Pharmaceuticals Sales Growth
    • 4.4 APAC Marine Pharmaceuticals Sales Growth
    • 4.5 Europe Marine Pharmaceuticals Sales Growth
    • 4.6 Middle East & Africa Marine Pharmaceuticals Sales Growth
  • 5 Americas

    • 5.1 Americas Marine Pharmaceuticals Sales by Country
      • 5.1.1 Americas Marine Pharmaceuticals Sales by Country (2019-2024)
      • 5.1.2 Americas Marine Pharmaceuticals Revenue by Country (2019-2024)
    • 5.2 Americas Marine Pharmaceuticals Sales by Type
    • 5.3 Americas Marine Pharmaceuticals Sales by Application
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil
  • 6 APAC

    • 6.1 APAC Marine Pharmaceuticals Sales by Region
      • 6.1.1 APAC Marine Pharmaceuticals Sales by Region (2019-2024)
      • 6.1.2 APAC Marine Pharmaceuticals Revenue by Region (2019-2024)
    • 6.2 APAC Marine Pharmaceuticals Sales by Type
    • 6.3 APAC Marine Pharmaceuticals Sales by Application
    • 6.4 China
    • 6.5 Japan
    • 6.6 South Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
    • 6.10 China Taiwan
  • 7 Europe

    • 7.1 Europe Marine Pharmaceuticals by Country
      • 7.1.1 Europe Marine Pharmaceuticals Sales by Country (2019-2024)
      • 7.1.2 Europe Marine Pharmaceuticals Revenue by Country (2019-2024)
    • 7.2 Europe Marine Pharmaceuticals Sales by Type
    • 7.3 Europe Marine Pharmaceuticals Sales by Application
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia
  • 8 Middle East & Africa

    • 8.1 Middle East & Africa Marine Pharmaceuticals by Country
      • 8.1.1 Middle East & Africa Marine Pharmaceuticals Sales by Country (2019-2024)
      • 8.1.2 Middle East & Africa Marine Pharmaceuticals Revenue by Country (2019-2024)
    • 8.2 Middle East & Africa Marine Pharmaceuticals Sales by Type
    • 8.3 Middle East & Africa Marine Pharmaceuticals Sales by Application
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers & Growth Opportunities
    • 9.2 Market Challenges & Risks
    • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis

    • 10.1 Raw Material and Suppliers
    • 10.2 Manufacturing Cost Structure Analysis of Marine Pharmaceuticals
    • 10.3 Manufacturing Process Analysis of Marine Pharmaceuticals
    • 10.4 Industry Chain Structure of Marine Pharmaceuticals
  • 11 Marketing, Distributors and Customer

    • 11.1 Sales Channel
      • 11.1.1 Direct Channels
      • 11.1.2 Indirect Channels
    • 11.2 Marine Pharmaceuticals Distributors
    • 11.3 Marine Pharmaceuticals Customer
  • 12 World Forecast Review for Marine Pharmaceuticals by Geographic Region

    • 12.1 Global Marine Pharmaceuticals Market Size Forecast by Region
      • 12.1.1 Global Marine Pharmaceuticals Forecast by Region (2025-2030)
      • 12.1.2 Global Marine Pharmaceuticals Annual Revenue Forecast by Region (2025-2030)
    • 12.2 Americas Forecast by Country
    • 12.3 APAC Forecast by Region
    • 12.4 Europe Forecast by Country
    • 12.5 Middle East & Africa Forecast by Country
    • 12.6 Global Marine Pharmaceuticals Forecast by Type
    • 12.7 Global Marine Pharmaceuticals Forecast by Application
  • 13 Key Players Analysis

    • 13.1 Seattle Genetics
      • 13.1.1 Seattle Genetics Company Information
      • 13.1.2 Seattle Genetics Marine Pharmaceuticals Product Portfolios and Specifications
      • 13.1.3 Seattle Genetics Marine Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.1.4 Seattle Genetics Main Business Overview
      • 13.1.5 Seattle Genetics Latest Developments
    • 13.2 DSM
      • 13.2.1 DSM Company Information
      • 13.2.2 DSM Marine Pharmaceuticals Product Portfolios and Specifications
      • 13.2.3 DSM Marine Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.2.4 DSM Main Business Overview
      • 13.2.5 DSM Latest Developments
    • 13.3 Eisai Co
      • 13.3.1 Eisai Co Company Information
      • 13.3.2 Eisai Co Marine Pharmaceuticals Product Portfolios and Specifications
      • 13.3.3 Eisai Co Marine Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.3.4 Eisai Co Main Business Overview
      • 13.3.5 Eisai Co Latest Developments
    • 13.4 Takeda
      • 13.4.1 Takeda Company Information
      • 13.4.2 Takeda Marine Pharmaceuticals Product Portfolios and Specifications
      • 13.4.3 Takeda Marine Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.4.4 Takeda Main Business Overview
      • 13.4.5 Takeda Latest Developments
    • 13.5 BASF
      • 13.5.1 BASF Company Information
      • 13.5.2 BASF Marine Pharmaceuticals Product Portfolios and Specifications
      • 13.5.3 BASF Marine Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.5.4 BASF Main Business Overview
      • 13.5.5 BASF Latest Developments
    • 13.6 Amway
      • 13.6.1 Amway Company Information
      • 13.6.2 Amway Marine Pharmaceuticals Product Portfolios and Specifications
      • 13.6.3 Amway Marine Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.6.4 Amway Main Business Overview
      • 13.6.5 Amway Latest Developments
    • 13.7 Pfizer
      • 13.7.1 Pfizer Company Information
      • 13.7.2 Pfizer Marine Pharmaceuticals Product Portfolios and Specifications
      • 13.7.3 Pfizer Marine Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.7.4 Pfizer Main Business Overview
      • 13.7.5 Pfizer Latest Developments
    • 13.8 Pelagia (EPAX)
      • 13.8.1 Pelagia (EPAX) Company Information
      • 13.8.2 Pelagia (EPAX) Marine Pharmaceuticals Product Portfolios and Specifications
      • 13.8.3 Pelagia (EPAX) Marine Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.8.4 Pelagia (EPAX) Main Business Overview
      • 13.8.5 Pelagia (EPAX) Latest Developments
    • 13.9 Pharma Mar SA
      • 13.9.1 Pharma Mar SA Company Information
      • 13.9.2 Pharma Mar SA Marine Pharmaceuticals Product Portfolios and Specifications
      • 13.9.3 Pharma Mar SA Marine Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.9.4 Pharma Mar SA Main Business Overview
      • 13.9.5 Pharma Mar SA Latest Developments
    • 13.10 Croda
      • 13.10.1 Croda Company Information
      • 13.10.2 Croda Marine Pharmaceuticals Product Portfolios and Specifications
      • 13.10.3 Croda Marine Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.10.4 Croda Main Business Overview
      • 13.10.5 Croda Latest Developments
    • 13.11 GNC
      • 13.11.1 GNC Company Information
      • 13.11.2 GNC Marine Pharmaceuticals Product Portfolios and Specifications
      • 13.11.3 GNC Marine Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.11.4 GNC Main Business Overview
      • 13.11.5 GNC Latest Developments
    • 13.12 GSK
      • 13.12.1 GSK Company Information
      • 13.12.2 GSK Marine Pharmaceuticals Product Portfolios and Specifications
      • 13.12.3 GSK Marine Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.12.4 GSK Main Business Overview
      • 13.12.5 GSK Latest Developments
    • 13.13 TerSera Therapeutics
      • 13.13.1 TerSera Therapeutics Company Information
      • 13.13.2 TerSera Therapeutics Marine Pharmaceuticals Product Portfolios and Specifications
      • 13.13.3 TerSera Therapeutics Marine Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.13.4 TerSera Therapeutics Main Business Overview
      • 13.13.5 TerSera Therapeutics Latest Developments
    • 13.14 Nordic Naturals
      • 13.14.1 Nordic Naturals Company Information
      • 13.14.2 Nordic Naturals Marine Pharmaceuticals Product Portfolios and Specifications
      • 13.14.3 Nordic Naturals Marine Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.14.4 Nordic Naturals Main Business Overview
      • 13.14.5 Nordic Naturals Latest Developments
    • 13.15 Carlson Labs
      • 13.15.1 Carlson Labs Company Information
      • 13.15.2 Carlson Labs Marine Pharmaceuticals Product Portfolios and Specifications
      • 13.15.3 Carlson Labs Marine Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.15.4 Carlson Labs Main Business Overview
      • 13.15.5 Carlson Labs Latest Developments
  • 14 Research Findings and Conclusion

USD 3,660 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.